Frank Pasqualone's Net Worth

$7.41 Million

Estimate Recalculated Nov 1, 2024 03:34AM EST

Who is Frank Pasqualone?

Frank Pasqualone has an estimated net worth of $7.41 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., and Enveric Biosciences, Inc..

SEC CIK

Frank Pasqualone's CIK is 0001597334

Past Insider Trading and Trends

2014 was Frank Pasqualone's most active year for acquiring shares with 3 total transactions. Frank Pasqualone's most active month to acquire stocks was the month of January. 2017 was Frank Pasqualone's most active year for disposing of shares, totalling 4 transactions. Frank Pasqualone's most active month to dispose stocks was the month of January. 2017 saw Frank Pasqualone paying a total of $105,358.80 for 13,000 shares, this is the most they've acquired in one year. In 2020 Frank Pasqualone cashed out on 37,034 shares for a total of $893,442.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

THERAVANCE INC (INVA) Snapshot price: $18.7201

Sr. Vice President, Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
20K
—
—
20K
Jan 23
Form 3
—
0
—
—
0
No matching records found

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01

SVP, CHIEF BUSINESS OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.87%
-3.78K
$8.36
-$31,592.44
429.78K
Nov 19
Form 4
-0.86%
-3.78K
$14.05
-$53,094.95
433.56K
Aug 20
Form 4
-0.86%
-3.78K
$17.80
-$67,266.20
437.34K
May 20
Form 4
-5.78%
-26.96K
$18.79
-$506,597.19
439.72K
Feb 20
Form 4
+16.18%
65K
—
—
466.68K
Feb 8
Form 4
-1.04%
-4.21K
$17.21
-$72,522.94
401.68K
Nov 20
Form 4
-1.03%
-4.21K
$18.22
-$76,779.08
405.89K
Aug 20
Form 4
-1.02%
-4.21K
$26.67
-$112,387.38
410.11K
May 20
Form 4
-5.58%
-24.39K
$25.90
-$631,752.80
412.92K
Feb 20
Form 4
+37.38%
119K
—
—
437.31K
Feb 3
Form 4
-0.76%
-2.45K
$17.60
-$43,067.20
318.31K
Nov 20
Form 4
-0.72%
-2.33K
$21.51
-$50,225.85
320.76K
Aug 20
Form 4
-0.49%
-1.60K
$19.84
-$31,823.36
323.09K
May 20
Form 4
-1.50%
-4.92K
$27.00
-$132,813.00
323.67K
Feb 20
Form 4
+51.89%
112.25K
—
—
328.59K
Feb 5
Form 4
-2.58%
-5.74K
$24.79
-$142,170.65
216.34K
Nov 20
Form 4
-2.52%
-5.74K
$26.95
-$154,558.25
222.07K
Aug 20
Form 4
-7.48%
-18.42K
$24.31
-$447,887.44
227.81K
May 20
Form 4
+15.88%
33.75K
—
—
246.23K
May 14
Form 4
-2.19%
-4.74K
$29.09
-$137,915.69
211.62K
Feb 20
Form 4
+4.34%
9K
—
—
216.36K
Feb 12
Form 4
-2.73%
-5.82K
$28.58
-$166,335.60
207.36K
Nov 20
Form 4
+1.91%
4K
$26.34
$105,358.80
213.18K
Aug 21
Form 4
-2.71%
-5.82K
$27.40
-$159,468.00
209.18K
Aug 20
Form 4
-2.64%
-5.82K
$36.83
-$214,350.60
215K
May 20
Form 4
-3.85%
-8.76K
$33.78
-$295,980.36
219.12K
Feb 20
Form 4
+4.11%
9K
—
—
227.88K
Feb 6
Form 4
+70.77%
90K
—
—
217.18K
Mar 15
Form 4
-7.85%
-10.83K
$15.65
-$169,489.50
127.18K
Feb 20
Form 4
+2,275.11%
130K
—
—
135.71K
Feb 5
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

Enveric Biosciences, Inc. (ENVB) Snapshot price: $0.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4,773.30%
47.73K
—
—
48.73K
Oct 9
Form 4
∞
1K
$2.14
$2,140.00
1K
Sep 15
Form 3
—
0
—
—
0
No matching records found